Rilpivirine HIV drug

Rilpivirine HIV drug

C026/1466 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 55.7MB

Downloadable file size: 10.8MB

Price image Pricing

Please login to use the price calculator


Restrictions: Editorial use only

Caption: Rilpivirine HIV drug. Person holding a box containing tablets of the non-nucleoside reverse transcriptase inhibitor drug rilpivirine, marketed under the name Edurant. This drug is used as a part of antiretroviral therapy in the treatment of HIV (human immunodeficiency virus). It slows the spread of HIV (human immunodeficiency virus) in the body by inhibiting reverse transcriptase, the enzyme that converts HIV RNA (ribonucleic acid) into viral DNA (deoxyribonucleic acid) that can be incorporated into human cells.

Release details: Model release not required. Property release not required.

Keywords: 21st century, 800mg, acquired immune deficiency syndrome, adult, aids, antiretroviral, box, boxed, caucasian, close-up, detail, drug, drugs, edurant, film-coated, hand, hands, healthcare, hiv, holding, human, human immunodeficiency virus, label, labeled, labelled, labels, medical, medication, medicine, non-nucleoside reverse transcriptase inhibitor, one person, oral, packaged, packaging, packet, people, pharmaceutic, pharmaceutical, pharmaceutics, pharmacological, pharmacology, pills, prescribed, prescription, rilpivirine, rti, tablet, tablets, treatment, white

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.